mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.084 |
0.02 |
mRNA |
neratinib |
CTRPv2 |
pan-cancer |
AAC |
-0.082 |
0.02 |
mRNA |
BRD-K13185470 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
0.02 |
mRNA |
GSK1070916 |
GDSC1000 |
pan-cancer |
AAC |
-0.074 |
0.02 |
mRNA |
NSC632839 |
CTRPv2 |
pan-cancer |
AAC |
0.078 |
0.02 |
mRNA |
thalidomide |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.02 |
mRNA |
leptomycin B |
CTRPv2 |
pan-cancer |
AAC |
0.077 |
0.02 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.075 |
0.02 |
mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.077 |
0.02 |
mRNA |
B02 |
CTRPv2 |
pan-cancer |
AAC |
0.082 |
0.02 |